Mediglim P 2mg/500mg/15mg Tablet
Marketer
Mediclove Biotech Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Mediglim P 2mg/500mg/15mg Tablet
Glimepiride-Metformin-Pioglitazone tablets (2mg/500mg/15mg) offer combined blood sugar management. This medication, used alongside diet and exercise, improves glycemic control in adult type 2 diabetics. It enhances insulin effectiveness, thus reducing blood glucose. Dosage and duration should strictly follow your physician's instructions. Administer with food to prevent gastric discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; in such cases, skip the missed dose. Never double the dose; overdose can trigger hypoglycemia. Concurrent use with other antidiabetic drugs, alcohol, or skipped meals may increase hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects encompass nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to use, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Kidney function assessment precedes treatment initiation. Limit alcohol consumption to mitigate potential adverse effects.
Primary Ingredients of Mediglim P 2mg/500mg/15mg Tablet
There is no text provided to rephrase.
Uses of Mediglim P 2mg/500mg/15mg Tablet
Managing Type 2 Diabetes
Major Benefits of Mediglim P 2mg/500mg/15mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or fracturing it. The Mediglim P 2mg/500mg/15mg Tablet should be administered with a meal.
Common Side effects of Mediglim P 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Mediglim P 2mg/500mg/15mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Mediglim P 2mg/500mg/15mg tablets with food.
How Mediglim P 2mg/500mg/15mg Tablet works:
Mediglim P 2mg/500mg/15mg tablets contain glimepiride, metformin, and pioglitazone—three antidiabetic agents with distinct actions. This triple combination enhances blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by reducing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further enhances insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Mediglim P 2mg/500mg/15mg Tablets should not be taken with alcohol.
PregnancyCONSULT YOUR DOCTOR
Use of Mediglim P 2mg/500mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential benefits against these risks prior to prescription. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Mediglim P 2mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when administering Mediglim P 2mg/500mg/15mg tablets to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician for guidance. The use of Mediglim P 2mg/500mg/15mg tablets is contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use the 2mg/500mg/15mg Mediglim P tablet cautiously, potentially requiring dosage modification. A physician's consultation is advised. The 2mg/500mg/15mg Mediglim P tablet is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Mediglim P 2mg/500mg/15mg Tablet :
Should you forget a Mediglim P 2mg/500mg/15mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mediglim P 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently